{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:08:00Z","timestamp":1790615280121,"version":"4.1.0"},"posted":{"date-parts":[[2026,5,20]]},"group-title":"In Review","reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,1]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Obesity is a major global public health challenge that contributes to numerous comorbidities and increased mortality. A better understanding of the biological mechanisms and disease risks associated with obesity requires robust monitoring of key circulating biomarkers, including adipokines, apolipoproteins, and inflammatory proteins. Targeted mass spectrometry (MS) offers a promising platform for developing specific, standardized, and multiplexed assays for biomarker quantification. In this study, we developed a multiplex targeted MS assay for the quantification of 42 obesity-associated biomarker candidates in human plasma.\n                  <bold>Methods:<\/bold>\n                  The assay was optimized for surrogate peptide selection, digestion incubation time, and LC gradient, and evaluated for linearity, lower limit of quantification (LLOQ), imprecision, and stability. A semi-automated sample preparation workflow using 96-well plates was also established to support high-throughput implementation. The assay was applied to a clinical cohort undergoing weight loss interventions to evaluate differences in protein abundance across obesity-related groups and to monitor biomarker changes over time. Statistical analyses were performed to identify proteins with significantly different abundances between study groups and before versus after intervention.\n                  <bold>Results:<\/bold>\n                  The assay demonstrated acceptable linearity, LLOQ, imprecision, and stability. Inter-laboratory validation using samples from 70 healthy individuals showed strong correlation with the finalized standard operating procedure (SOP). Application of the assay to an obesity cohort revealed significant differences in the levels of 6 proteins across obese, overweight, and healthy control groups, as well as 16 proteins that were differentially abundant in obese individuals compared with non-obese individuals (overweight and healthy controls combined). In subjects undergoing weight loss interventions, four proteins\u2014CRP, PRG4, SERPINF1, and SHBG\u2014showed significant concentration changes in individuals who achieved\u2009&gt;\u20095% weight loss.\n                  <bold>Conclusions:<\/bold>\n                  These results demonstrate the robustness and high-throughput capability of this multiplex targeted MS assay for measuring obesity-associated plasma biomarkers. The assay shows potential clinical utility for improving the diagnosis, stratification, and risk assessment of obesity-related conditions, as well as for monitoring responses to weight loss interventions.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9588456\/v1","type":"posted-content","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:10:57Z","timestamp":1779257457000},"source":"Crossref","is-referenced-by-count":0,"title":["A multiplexed targeted mass spectrometric assay for quantifying obesity- associated biomarkers in human plasma"],"prefix":"10.21203","author":[{"given":"Tai-Tu","family":"Lin","sequence":"first","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panshak","family":"Dakup","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena A.","family":"Schepmoes","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Fillmore","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Swensen","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane S","family":"Kelly","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pu","sequence":"additional","affiliation":[{"name":"University at Buffalo, State University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"DeLany","sequence":"additional","affiliation":[{"name":"Advent Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret H.","family":"Goodpaster","sequence":"additional","affiliation":[{"name":"Advent Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tujin","family":"Shi","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qu","sequence":"additional","affiliation":[{"name":"University at Buffalo, State University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Qian","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"10021","key":"ref1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(16)00140-9","article-title":"Ending childhood obesity: a time for action","volume":"387","author":"Nishtar S","year":"2016","unstructured":"Nishtar S, Gluckman P, Armstrong T. Ending childhood obesity: a time for action. Lancet. 2016;387(10021):825\u20137.","journal-title":"Lancet"},{"issue":"6778","key":"ref2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/35007508","article-title":"Obesity as a medical problem","volume":"404","author":"Kopelman PG","year":"2000","unstructured":"Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635\u201343.","journal-title":"Nature"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3810\/pgm.2009.11.2074","article-title":"The medical risks of obesity","volume":"121","author":"Pi-Sunyer X","year":"2009","unstructured":"Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121(6):21\u201333.","journal-title":"Postgrad Med"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health Effects of Overweight and Obesity in 195 Countries over 25 Years","volume":"377","author":"Collaborators GBDO","year":"2017","unstructured":"Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13\u201327.","journal-title":"N Engl J Med"},{"key":"ref5","author":"Klein S","year":"2004","unstructured":"Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH, American Heart Association Council on Nutrition PA., Metabolism: Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004, 110(18):2952\u20132967."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-42542-9_1","article-title":"Obesity and Risk of Cancer: An Introductory Overview","volume":"208","author":"Pischon T","year":"2016","unstructured":"Pischon T, Nimptsch K. Obesity and Risk of Cancer: An Introductory Overview. Recent Results Cancer Res. 2016;208:1\u201315.","journal-title":"Recent Results Cancer Res"},{"issue":"5\u20136","key":"ref7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1155\/2009\/757683","article-title":"Use of obesity biomarkers in cardiovascular epidemiology","volume":"26","author":"Pischon T","year":"2009","unstructured":"Pischon T. Use of obesity biomarkers in cardiovascular epidemiology. Dis Markers. 2009;26(5\u20136):247\u201363.","journal-title":"Dis Markers"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/clinchem\/47.3.403","article-title":"High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease","volume":"47","author":"Rifai N","year":"2001","unstructured":"Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001;47(3):403\u201311.","journal-title":"Clin Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.acc.2016.03.002","article-title":"Transferrin Saturation: A Body Iron Biomarker","volume":"75","author":"Elsayed ME","year":"2016","unstructured":"Elsayed ME, Sharif MU, Stack AG. Transferrin Saturation: A Body Iron Biomarker. Adv Clin Chem. 2016;75:71\u201397.","journal-title":"Adv Clin Chem"},{"issue":"1\u20132","key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","article-title":"The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry","volume":"347","author":"Hoofnagle AN","year":"2009","unstructured":"Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009;347(1\u20132):3\u201311.","journal-title":"J Immunol Methods"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nmeth.2015","article-title":"Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions","volume":"9","author":"Picotti P","year":"2012","unstructured":"Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9(6):555\u201366.","journal-title":"Nat Methods"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M700354-MCP200","article-title":"Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution","volume":"6","author":"Keshishian H","year":"2007","unstructured":"Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteom. 2007;6(12):2212\u201329.","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","article-title":"Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins","volume":"5","author":"Anderson L","year":"2006","unstructured":"Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteom. 2006;5(4):573\u201388.","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040775","article-title":"An MRM-Based Multiplexed Quantification Assay for Human Adipokines and Apolipoproteins","volume":"25","author":"Krieg L","year":"2020","unstructured":"Krieg L, Schaffert A, Kern M, Landgraf K, Wabitsch M, Beck-Sickinger AG, Koerner A, Bluher M, von Bergen M, Schubert K. An MRM-Based Multiplexed Quantification Assay for Human Adipokines and Apolipoproteins. Molecules 2020, 25(4).","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"578966","DOI":"10.3389\/fphys.2020.578966","article-title":"Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases","volume":"11","author":"Recinella L","year":"2020","unstructured":"Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S. Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases. Front Physiol. 2020;11:578966.","journal-title":"Front Physiol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu MS","year":"2017","unstructured":"Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851\u201363.","journal-title":"Arch Med Sci"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino LK","year":"2020","unstructured":"Pino LK, Searle BC, Bollinger JG, Nunn B, MacLean B, MacCoss MJ. The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics. Mass Spectrom Rev. 2020;39(3):229\u201344.","journal-title":"Mass Spectrom Rev"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1158\/1055-9965.EPI-20-0192","article-title":"Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance","volume":"29","author":"Lee JY","year":"2020","unstructured":"Lee JY, Shi T, Petyuk VA, Schepmoes AA, Fillmore TL, Wang YT, Cardoni W, Coppit G, Srivastava S, Goodman JF, et al. Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance. Cancer Epidemiol Biomarkers Prev. 2020;29(8):1665\u201372.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1021\/ac961912f","article-title":"A Practical Guide to Analytical Method Validation","volume":"68","author":"Peer Reviewed","year":"1996","unstructured":"Peer Reviewed. A Practical Guide to Analytical Method Validation. Anal Chem. 1996;68(9):A305\u20139.","journal-title":"Anal Chem"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13679-020-00393-y","article-title":"Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention","volume":"9","author":"Aleksandrova K","year":"2020","unstructured":"Aleksandrova K, Egea Rodrigues C, Floegel A, Ahrens W. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention. Curr Obes Rep. 2020;9(3):219\u201330.","journal-title":"Curr Obes Rep"},{"key":"ref21","unstructured":"GitHub. Available from: https:\/\/github.com\/evanamartin\/genescraper"},{"key":"ref22","unstructured":"FDA. Table of Pharmacogenomic Biomarkers in Drug Labeling. In. Edited by Administration USFaD; 2022."},{"key":"ref23","unstructured":"FDA. List of Qualified Biomarkers. In. Edited by Administration USFaD; 2022."},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma Proteome Profiling to Assess Human Health and Disease","volume":"2","author":"Geyer PE","year":"2016","unstructured":"Geyer PE, Kulak NA, Pichler G, Holdt LM, Teupser D, Mann M. Plasma Proteome Profiling to Assess Human Health and Disease. Cell Syst. 2016;2(3):185\u201395.","journal-title":"Cell Syst"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cels.2018.10.012","article-title":"Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery","volume":"7","author":"Wewer Albrechtsen NJ","year":"2018","unstructured":"Wewer Albrechtsen NJ, Geyer PE, Doll S, Treit PV, Bojsen-Moller KN, Martinussen C, Jorgensen NB, Torekov SS, Meier F, Niu L, et al. Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery. Cell Syst. 2018;7(6):601\u201312. e603.","journal-title":"Cell Syst"},{"issue":"3","key":"ref26","first-page":"e8793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu L","year":"2019","unstructured":"Niu L, Geyer PE, Wewer Albrechtsen NJ, Gluud LL, Santos A, Doll S, Treit PV, Holst JJ, Knop FK, Vilsboll T, et al. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol Syst Biol. 2019;15(3):e8793.","journal-title":"Mol Syst Biol"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"e10427","DOI":"10.15252\/emmm.201910427","article-title":"Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies","volume":"11","author":"Geyer PE","year":"2019","unstructured":"Geyer PE, Voytik E, Treit PV, Doll S, Kleinhempel A, Niu L, Muller JB, Buchholtz ML, Bader JM, Teupser D, et al. Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies. EMBO Mol Med. 2019;11(11):e10427.","journal-title":"EMBO Mol Med"},{"key":"ref28","first-page":"8","article-title":"In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta","author":"Pernemalm M","year":"2019","unstructured":"Pernemalm M, Sandberg A, Zhu Y, Boekel J, Tamburro D, Schwenk JM, Bjork A, Wahren-Herlenius M, Amark H, Ostenson CG et al. In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta. Elife 2019, 8.","journal-title":"Elife"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner M","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"D1","key":"ref30","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The Gene Ontology resource: enriching a GOld mine","volume":"49","author":"Gene Ontology C","year":"2021","unstructured":"Gene Ontology C. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 2021;49(D1):D325\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa M","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa M","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"key":"ref33","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","author":"Kanehisa M","year":"2022","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res 2022.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kramer A","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523\u201330.","journal-title":"Bioinformatics"},{"key":"ref35","author":"Inc. Q","unstructured":"Inc. Q. QIAGEN IPA. In."},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1074\/mcp.M114.044321","article-title":"Abundance-based classifier for the prediction of mass spectrometric peptide detectability upon enrichment (PPA)","volume":"14","author":"Muntel J","year":"2015","unstructured":"Muntel J, Boswell SA, Tang S, Ahmed S, Wapinski I, Foley G, Steen H, Springer M. Abundance-based classifier for the prediction of mass spectrometric peptide detectability upon enrichment (PPA). Mol Cell Proteom. 2015;14(2):430\u201340.","journal-title":"Mol Cell Proteom"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"M110003384","DOI":"10.1074\/mcp.M110.003384","article-title":"CONSeQuence: prediction of reference peptides for absolute quantitative proteomics using consensus machine learning approaches","volume":"10","author":"Eyers CE","year":"2011","unstructured":"Eyers CE, Lawless C, Wedge DC, Lau KW, Gaskell SJ, Hubbard SJ. CONSeQuence: prediction of reference peptides for absolute quantitative proteomics using consensus machine learning approaches. Mol Cell Proteom. 2011;10(11):M110003384.","journal-title":"Mol Cell Proteom"},{"issue":"Database issue","key":"ref38","doi-asserted-by":"crossref","first-page":"D655","DOI":"10.1093\/nar\/gkj040","article-title":"The PeptideAtlas project","volume":"34","author":"Desiere F","year":"2006","unstructured":"Desiere F, Deutsch EW, King NL, Nesvizhskii AI, Mallick P, Eng J, Chen S, Eddes J, Loevenich SN, Aebersold R. The PeptideAtlas project. Nucleic Acids Res. 2006;34(Database issue):D655\u2013658.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"ref39","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2010.1505","article-title":"Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial","volume":"304","author":"Goodpaster BH","year":"2010","unstructured":"Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTigue K, Hames KC, et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA. 2010;304(16):1795\u2013802.","journal-title":"JAMA"},{"key":"ref40","first-page":"i","article-title":"preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","author":"Obesity","year":"2000","unstructured":"Obesity. preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i\u2013xii.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"3\u20134","key":"ref41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: potentials and pitfalls","volume":"9","author":"Tighe PJ","year":"2015","unstructured":"Tighe PJ, Ryder RR, Todd I, Fairclough LC. ELISA in the multiplex era: potentials and pitfalls. Proteom Clin Appl. 2015;9(3\u20134):406\u201322.","journal-title":"Proteom Clin Appl"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1373\/clinchem.2013.215236","article-title":"False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125","volume":"60","author":"Prassas I","year":"2014","unstructured":"Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, Brand R, Kulasingam V, Blasutig IM, Diamandis EP. False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125. Clin Chem. 2014;60(2):381\u20138.","journal-title":"Clin Chem"},{"issue":"15","key":"ref43","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJMc1502602","article-title":"Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry","volume":"373","author":"Hoofnagle AN","year":"2015","unstructured":"Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. N Engl J Med. 2015;373(15):1480\u20132.","journal-title":"N Engl J Med"},{"issue":"17","key":"ref44","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMc1513502","article-title":"Role of Assay Type in Determining Free 25-Hydroxyvitamin D Levels in Diverse Populations","volume":"374","author":"Nielson CM","year":"2016","unstructured":"Nielson CM, Jones KS, Bouillon R, Osteoporotic Fractures in Men, Research G, Chun RF, Jacobs J, Wang Y, Hewison M, Adams JS, Swanson CM, et al. Role of Assay Type in Determining Free 25-Hydroxyvitamin D Levels in Diverse Populations. N Engl J Med. 2016;374(17):1695\u20136.","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/msb.2008.61","article-title":"Selected reaction monitoring for quantitative proteomics: a tutorial","volume":"4","author":"Lange V","year":"2008","unstructured":"Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008;4:222.","journal-title":"Mol Syst Biol"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin D","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785\u201397.","journal-title":"Nat Immunol"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0b013e328329233b","article-title":"Lecithin: cholesterol acyltransferase\u2013from biochemistry to role in cardiovascular disease","volume":"16","author":"Rousset X","year":"2009","unstructured":"Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT. Lecithin: cholesterol acyltransferase\u2013from biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes. 2009;16(2):163\u201371.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2018.11.009","article-title":"Proteoglycan 4 deficiency protects against glucose intolerance and fatty liver disease in diet-induced obese mice","volume":"1865","author":"Nahon JE","year":"2019","unstructured":"Nahon JE, Hoekstra M, van Harmelen V, Rensen PCN, van Willems K, Kooijman S, Van Eck M. Proteoglycan 4 deficiency protects against glucose intolerance and fatty liver disease in diet-induced obese mice. Biochim Biophys Acta Mol Basis Dis. 2019;1865(2):494\u2013501.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15025","article-title":"Anticoagulant protein S-New insights on interactions and functions","volume":"18","author":"Gierula M","year":"2020","unstructured":"Gierula M, Ahnstrom J. Anticoagulant protein S-New insights on interactions and functions. J Thromb Haemost. 2020;18(11):2801\u201311.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/db10-0845","article-title":"Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase","volume":"60","author":"Borg ML","year":"2011","unstructured":"Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes. 2011;60(5):1458\u201366.","journal-title":"Diabetes"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ije\/dyq158","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"40","author":"Brand JS","year":"2011","unstructured":"Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011;40(1):189\u2013207.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/cen.12768","article-title":"The association of obesity with sex hormone-binding globulin is stronger than the association with ageing\u2013implications for the interpretation of total testosterone measurements","volume":"83","author":"Cooper LA","year":"2015","unstructured":"Cooper LA, Page ST, Amory JK, Anawalt BD, Matsumoto AM. The association of obesity with sex hormone-binding globulin is stronger than the association with ageing\u2013implications for the interpretation of total testosterone measurements. Clin Endocrinol (Oxf). 2015;83(6):828\u201333.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4\u20136","key":"ref53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0960-0760(91)90310-2","article-title":"Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin","volume":"40","author":"Pugeat M","year":"1991","unstructured":"Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune H, Dechaud H, Tourniaire J. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol. 1991;40(4\u20136):841\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.metabol.2018.12.006","article-title":"Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine","volume":"92","author":"Nimptsch K","year":"2019","unstructured":"Nimptsch K, Konigorski S, Pischon T. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism. 2019;92:61\u201370.","journal-title":"Metabolism"},{"issue":"22","key":"ref55","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser M","year":"1999","unstructured":"Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131\u20135.","journal-title":"JAMA"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18632\/aging.100004","article-title":"Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging","volume":"1","author":"Perdomo G","year":"2009","unstructured":"Perdomo G, Henry Dong H. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging. 2009;1(1):17\u201327.","journal-title":"Aging"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2021.08.039","article-title":"Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system","volume":"334","author":"Yao Mattisson I","year":"2021","unstructured":"Yao Mattisson I, Christoffersen C. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system. Atherosclerosis. 2021;334:76\u201384.","journal-title":"Atherosclerosis"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"901","DOI":"10.15252\/msb.20167357","article-title":"Proteomics reveals the effects of sustained weight loss on the human plasma proteome","volume":"12","author":"Geyer PE","year":"2016","unstructured":"Geyer PE, Wewer Albrechtsen NJ, Tyanova S, Grassl N, Iepsen EW, Lundgren J, Madsbad S, Holst JJ, Torekov SS, Mann M. Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Mol Syst Biol. 2016;12(12):901.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.1038\/s41598-018-35321-7","article-title":"Obesity shows preserved plasma proteome in large independent clinical cohorts","volume":"8","author":"Cominetti O","year":"2018","unstructured":"Cominetti O, Nunez Galindo A, Corthesy J, Valsesia A, Irincheeva I, Kussmann M, Saris WHM, Astrup A, McPherson R, Harper ME, et al. Obesity shows preserved plasma proteome in large independent clinical cohorts. Sci Rep. 2018;8(1):16981.","journal-title":"Sci Rep"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pcad.2013.09.012","article-title":"The role of exercise and physical activity in weight loss and maintenance","volume":"56","author":"Swift DL","year":"2014","unstructured":"Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis. 2014;56(4):441\u20137.","journal-title":"Prog Cardiovasc Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9588456\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9588456\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:14:21Z","timestamp":1790612061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9588456\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":60,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9588456\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12014-026-09625-0","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,5,20]]},"subtype":"preprint"}}